Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | |
| Fformat: | Traethawd Ymchwil |
| Iaith: | English |
| Cyhoeddwyd: |
Brac University
2024
|
| Pynciau: | |
| Mynediad Ar-lein: | http://hdl.handle.net/10361/23144 |
| id |
10361-23144 |
|---|---|
| record_format |
dspace |
| spelling |
10361-231442024-06-05T21:03:13Z Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies Alam, Tahera Azam, Faruque School of Pharmacy, Brac University Prostate cancer Benign Prostatic Hyperplasia Prostate-specific antigen Cancer therapy Prostate--Cancer--Treatment Benign prostatic hyperplasia This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from the PDF version of thesis. Includes bibliographical references (pages 25-35). About 15% of prostate cancer diagnoses are due to high-risk conditions and the best way to treat this patient are always changing. To allow the accurate identification of high-risk illnesses and the creation of more effective treatment pattern, a new classification method is necessary. The Food & Drug Administration has authorized the newest innovative prostate-specific membrane antigen Pluvicto as a prostate cancer therapy. A percent of old citizens that do meet the criteria for the prostate-specific membrane antigen and have prostate cancer which is known as metastatic castration-resistant prostate cancer are now advised to use Pluvicto. Biomarkers are substances that are used to reveal either regular or irregular bodily activities for determining prostate cancer by prostate-specific antigen, 4 Kallikreins score, and prostate cancer gene 3 level. Moreover, this project highlights the advanced treatment strategies along with their mechanisms to cure prostate cancer and benign prostatic hyperplasia. Tahera Alam B. Pharmacy 2024-06-05T05:44:02Z 2024-06-05T05:44:02Z ©2023 2023-03 Thesis ID: 18346004 http://hdl.handle.net/10361/23144 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 47 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Prostate cancer Benign Prostatic Hyperplasia Prostate-specific antigen Cancer therapy Prostate--Cancer--Treatment Benign prostatic hyperplasia |
| spellingShingle |
Prostate cancer Benign Prostatic Hyperplasia Prostate-specific antigen Cancer therapy Prostate--Cancer--Treatment Benign prostatic hyperplasia Alam, Tahera Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. |
| author2 |
Azam, Faruque |
| author_facet |
Azam, Faruque Alam, Tahera |
| format |
Thesis |
| author |
Alam, Tahera |
| author_sort |
Alam, Tahera |
| title |
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| title_short |
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| title_full |
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| title_fullStr |
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| title_full_unstemmed |
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies |
| title_sort |
benign prostatic hyperplasia & prostate cancer: a review on the treatment strategies |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/23144 |
| work_keys_str_mv |
AT alamtahera benignprostatichyperplasiaprostatecancerareviewonthetreatmentstrategies |
| _version_ |
1814308500925317120 |